Casey Woodring
Stock Analyst at JP Morgan
(0.52)
# 4,100
Out of 4,944 analysts
34
Total ratings
25%
Success rate
-18.93%
Average return
Main Sectors:
Stocks Rated by Casey Woodring
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CRL Charles River Laboratories International | Maintains: Neutral | $145 → $160 | $155.00 | +3.23% | 8 | Aug 7, 2025 | |
| ICLR ICON Public Limited Company | Downgrades: Neutral | $265 → $150 | $176.29 | -14.91% | 6 | Apr 29, 2025 | |
| QDEL QuidelOrtho | Maintains: Underweight | $38 → $25 | $27.08 | -7.68% | 4 | Apr 21, 2025 | |
| HOLX Hologic | Maintains: Overweight | $92 → $94 | $68.98 | +36.27% | 5 | Nov 5, 2024 | |
| QGEN Qiagen | Maintains: Overweight | $54 → $56 | $49.23 | +12.98% | 4 | Jun 18, 2024 | |
| OSUR OraSure Technologies | Maintains: Neutral | $7 → $6 | $2.85 | +110.53% | 3 | May 13, 2024 | |
| EGBN Eagle Bancorp | Maintains: Neutral | $25 → $23 | $18.12 | +26.93% | 2 | Oct 31, 2023 | |
| SHC Sotera Health Company | Upgrades: Neutral | $6 → $18 | $15.72 | +14.50% | 2 | Jan 23, 2023 |
Charles River Laboratories International
Aug 7, 2025
Maintains: Neutral
Price Target: $145 → $160
Current: $155.00
Upside: +3.23%
ICON Public Limited Company
Apr 29, 2025
Downgrades: Neutral
Price Target: $265 → $150
Current: $176.29
Upside: -14.91%
QuidelOrtho
Apr 21, 2025
Maintains: Underweight
Price Target: $38 → $25
Current: $27.08
Upside: -7.68%
Hologic
Nov 5, 2024
Maintains: Overweight
Price Target: $92 → $94
Current: $68.98
Upside: +36.27%
Qiagen
Jun 18, 2024
Maintains: Overweight
Price Target: $54 → $56
Current: $49.23
Upside: +12.98%
OraSure Technologies
May 13, 2024
Maintains: Neutral
Price Target: $7 → $6
Current: $2.85
Upside: +110.53%
Eagle Bancorp
Oct 31, 2023
Maintains: Neutral
Price Target: $25 → $23
Current: $18.12
Upside: +26.93%
Sotera Health Company
Jan 23, 2023
Upgrades: Neutral
Price Target: $6 → $18
Current: $15.72
Upside: +14.50%